title: Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).
abstract: We measured candidate urine biomarkers and bladder cell DNA cytometry in interstitial cystitis (IC) patients randomized to receive intravesical Bacillus Calmette Guerin (BCG) or placebo in a multicenter trial. Participants received 6 weekly instillations and were followed for 34 weeks. Urine was collected at baseline, prior to fourth treatment, and at study end. Antiproliferative factor (APF) activity was determined by 3H-thymidine incorporation assay; heparin-binding epidermal growth factor-like growth factor (HB-EGF) and epidermal growth factor-like growth factor (EGF) levels were determined by ELISA. Cellular DNA content was measured by image analysis to determine the mean hyperdiploid fraction (HDF) of the urine cell pellet. Associations between marker levels, and treatment or symptoms, were examined. Baseline APF positivity rate and mean levels of the other biomarkers were similar to previous smaller studies. During the week 34 follow-up, mean HDF decreased (P = 0.0003) and HB-EGF increased (P < 0.0001); both correlated weakly with decreased urgency. There was no difference in any biomarker between symptom responders and non-responders, but the percentage of responders was low and not significantly different for BCG versus placebo. APF positivity, decreased HB-EGF, increased EGF, and increased HDF were confirmed at baseline in IC patients. Changes in HDF and HB-EGF levels correlated weakly with changes in urgency, but the low BCG response rate prevented identification of additional associations between biomarker changes and treatment or symptoms.
authors: Department of Medicine, University of Maryland School of Medicine, 10 N. Greene Street, Baltimore, MD 21201, USA. skeay@medicine.umaryland.edu
authors: Susan
authors: S
authors: Keay
authors: Jay E
authors: JE
authors: Reeder
authors: Kristopher
authors: K
authors: Koch
authors: Chen-Ou
authors: CO
authors: Zhang
authors: Daivd
authors: D
authors: Grkovic
authors: Kenneth
authors: K
authors: Peters
authors: Yawei
authors: Y
authors: Zhang
authors: John W
authors: JW
authors: Kusek
authors: Lee M
authors: LM
authors: Nyberg
authors: Christopher K
authors: CK
authors: Payne
authors: Kathleen J
authors: KJ
authors: Propert
mesh_terms: D000283:Administration, Intravesical; D000328:Adult; D015415:Biomarkers / Q000652:urine; D018856:Cystitis, Interstitial / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine*; D004311:Double-Blind Method; D004847:Epithelial Cells / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009163:Mycobacterium bovis; D011446:Prospective Studies; D001743:Urinary Bladder / Q000166:cytology / Q000187:drug effects
chemical_list: D015415:Biomarkers
references: BMC Urol. 2004 Apr 06;4:3
references: 15068487
references: Urology. 2001 Jun;57(6 Suppl 1):15-21
references: 11378044
references: Urology. 2000 May;55(5):643-6
references: 10792070
references: BMC Urol. 2005 Apr 29;5:7
references: 15862132
references: J Urol. 2003 Sep;170(3):810-5
references: 12913705
references: Urology. 1998 Dec;52(6):1026-9
references: 9836549
references: J Urol. 1988 Jul;140(1):203-6
references: 3379688
references: J Urol. 1997 Dec;158(6):2045-50
references: 9366309
references: Mead Johnson Symp Perinat Dev Med. 1988;(32):33-40
references: 2485437
references: J Urol. 2002 Jun;167(6):2461-9
references: 11992058
references: Gut. 1998 Feb;42(2):235-42
references: 9536949
references: J Urol. 2005 Apr;173(4):1186-91
references: 15758738
references: Urology. 2001 Jun;57(6 Suppl 1):9-14
references: 11378043
references: Med Decis Making. 1996 Jan-Mar;16(1):78-85
references: 8717602
references: J Urol. 2004 Dec;172(6 Pt 1):2256-60
references: 15538243
references: J Urol. 1994 Dec;152(6 Pt 2):2262-6
references: 7525999
references: J Urol. 1996 Dec;156(6):2073-8
references: 8911393
references: Urology. 2002 Jul;60(1):46-51
references: 12100920
references: J Clin Endocrinol Metab. 1977 Oct;45(4):668-72
references: 303242
references: Urology. 1990 Jun;35(6):552-8
references: 1693797
references: Br J Urol. 1995 May;75(5):622-30
references: 7542132
references: J Urol. 2000 May;163(5):1440-4
references: 10751853
references: Urology. 2001 Jun;57(6 Suppl 1):67-81
references: 11378053
references: Acta Endocrinol (Copenh). 1990 Dec;123(6):643-8
references: 2284889
references: J Urol. 2000 Dec;164(6):2112-8
references: 11061938
references: Urology. 1998 Dec;52(6):974-8
references: 9836539
references: Cornea. 2004 Nov;23(8):762-70
references: 15502475
references: J Urol. 1997 Nov;158(5):1983-8
references: 9334654
references: Pediatr Res. 1985 May;19(5):428-32
references: 3873640
references: J Endocrinol. 1985 Aug;106(2):197-202
references: 3874924